Insider Transactions in Q1 2021 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2021
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
177,750
+28.36%
|
-
|
|
Mar 30
2021
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
281,250
+25.36%
|
-
|
|
Mar 30
2021
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
132,750
+28.32%
|
-
|
|
Mar 30
2021
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
121,500
+32.68%
|
-
|
|
Mar 30
2021
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
303,750
+25.14%
|
-
|
|
Feb 18
2021
|
Thomas John Dietz Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+23.08%
|
-
|
|
Feb 18
2021
|
Timothy R Franson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+18.75%
|
-
|
|
Feb 18
2021
|
Rolf K Hoffmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+16.98%
|
-
|
|
Feb 18
2021
|
Kristine Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+18.75%
|
-
|
|
Feb 18
2021
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+21.82%
|
-
|
|
Feb 18
2021
|
Jeffrey Stein Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+20.17%
|
-
|